The top pre-market NASDAQ stock market gainers are: BioSante Pharmaceuticals, Harris & Harris Group, LM Ericsson Telephone, Savient Pharmaceuticals, and Skyworks Solutions. The top pre-market NASDAQ stock market losers are: Tellabs, Eagle Bulk Shipping, Rediff.com India, Randgold Resources, and DryShips.
German researchers say they have cured a man of HIV infection that could prove to be a scientific advance but researchers familiar with the work feel it is not necessarily a treatment advance.
Swiss drug maker Novartis will pay $12.9 billion to buy the remaining shares of Alcon it doesn't already own to broaden its presence in the booming eye-care market, which is expected to outgrow the pharmaceuticals market in coming years.
The top pre-market NASDAQ stock market gainers are: Verigy, Radware, Rambus, Nova Measuring Instruments, ASM International, VIVUS, optionsXpress Holdings, Ariad Pharmaceuticals, Geron, and DryShips.
U.S. health regulators approved Roche's (ROG.VX) blockbuster cancer drug Rituxan to treat the most common form of leukemia in adults.
